We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$14.6B
AUM Growth
-$1.02B
Cap. Flow
-$902M
Cap. Flow %
-6.19%
Top 10 Hldgs %
33.67%
Holding
1,168
New
194
Increased
342
Reduced
403
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$56M
2
CSCO icon
Cisco
CSCO
+$49.4M
3
META icon
Meta Platforms (Facebook)
META
+$45.4M
4
CVE icon
Cenovus Energy
CVE
+$40.5M
5
BNS icon
Scotiabank
BNS
+$39.8M

Sector Composition

Rank Sector Weight
1 Financials 27.48%
2 Energy 13.55%
3 Industrials 13.52%
4 Technology 10.79%
5 Materials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
301
Lantheus
LNTH
$6.59B
$3.8M 0.03%
151,528
-51,375
-25% -$1.26M
TMHC
302
DELISTED
Taylor Morrison
TMHC
$3.78M 0.03%
+145,675
New +$3.36M
CIB icon
303
Grupo Cibest SA
CIB
$22.8B
$3.78M 0.03%
76,400
+42,375
+125% +$2.14M
STI
304
DELISTED
SunTrust Banks, Inc.
STI
$3.77M 0.03%
54,783
-200
-0.4% -$12.8K
UFS
305
DELISTED
DOMTAR CORPORATION (New)
UFS
$3.77M 0.03%
+105,100
New +$3.9M
CPRT icon
306
Copart
CPRT
$26.9B
$3.75M 0.03%
+186,900
New +$3.63M
HLF icon
307
Herbalife
HLF
$1.27B
$3.67M 0.03%
96,990
+5,775
+6% +$225K
WBA
308
DELISTED
Walgreens Boots Alliance
WBA
$3.67M 0.03%
66,254
-13,075
-16% -$701K
DEO icon
309
Diageo
DEO
$52.8B
$3.66M 0.03%
22,385
+35
+0.2% +$5.86K
HBM icon
310
Hudbay
HBM
$11.9B
$3.65M 0.03%
1,011,415
+123,951
+14% +$505K
SLB icon
311
SLB Ltd
SLB
$77.3B
$3.62M 0.02%
106,055
-422,000
-80% -$15.4M
GILD icon
312
Gilead Sciences
GILD
$170B
$3.61M 0.02%
57,007
-15,300
-21% -$1M
MX icon
313
Magnachip Semiconductor
MX
$139M
$3.61M 0.02%
355,803
-16,049
-4% -$169K
UTHR icon
314
United Therapeutics
UTHR
$21.7B
$3.58M 0.02%
44,858
-24,217
-35% -$1.95M
LYG icon
315
Lloyds Banking Group
LYG
$90B
$3.54M 0.02%
1,339,480
+2,081
+0.2% +$5.4K
GEN icon
316
Gen Digital
GEN
$17.2B
$3.48M 0.02%
147,264
+46,809
+47% +$1.09M
MCO icon
317
Moody's
MCO
$82.7B
$3.48M 0.02%
16,969
-24,975
-60% -$5.24M
BIO icon
318
Bio-Rad Laboratories Class A
BIO
$9.62B
$3.47M 0.02%
10,425
+5,475
+111% +$1.79M
M icon
319
Macy's
M
$6.19B
$3.44M 0.02%
+221,317
New +$4.1M
QUAD icon
320
Quad
QUAD
$502M
$3.44M 0.02%
327,022
-32,049
-9% -$300K
KDP icon
321
Keurig Dr Pepper
KDP
$42.3B
$3.4M 0.02%
124,418
-42,200
-25% -$1.18M
CNX icon
322
CNX Resources
CNX
$5.23B
$3.35M 0.02%
461,858
+131,308
+40% +$983K
EGP icon
323
EastGroup Properties
EGP
$11B
$3.34M 0.02%
26,750
-14,600
-35% -$1.78M
SWCH
324
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$3.34M 0.02%
+213,852
New +$3.17M
CARS icon
325
Cars.com
CARS
$651M
$3.33M 0.02%
+370,319
New +$5M

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2019 Portfolio in Review

As of Q3 2019, Connor, Clark & Lunn Investment Management (CC&L) held 1,168 positions worth $14.6B, down 6.5% from $15.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $902M in Q3 2019, closing 225 positions and reducing 403 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $37.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Fidelity National Information Services worth $29.9M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2019 buy was Fidelity National Information Services: 225,271 shares worth $29.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Pfizer in Q3 2019, an estimated $56M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2019 reduction was Toronto Dominion Bank, cutting an estimated $105M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Bristol-Myers Squibb in Q3 2019, selling an estimated $37.2M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 34% of its $14.6B portfolio in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 194 new positions and closed 225 in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 6.5% quarter-over-quarter to $14.6B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2019, filed 13 Nov 2019.